PT - JOURNAL ARTICLE AU - Yi Wang AU - Xiaoxia Wang AU - Laurence Don Wai Luu AU - Jieqiong Li AU - Xiaodai Cui AU - Hailan Yao AU - Xin Zhang AU - Shaojin Chen AU - Jin Fu AU - Licheng Wang AU - Chongzhen Wang AU - Rui Yuan AU - Qingguo Cai AU - Xiaolan Huang AU - Junfei Huang AU - Wenjian Xu AU - Shijun Li AU - Xiong Zhu AU - Jun Tai TI - Single-cell transcriptomic atlas of individuals receiving inactivated COVID-19 vaccines reveals distinct immunological responses between vaccine and natural SARS-CoV-2 infection AID - 10.1101/2021.08.30.21262863 DP - 2021 Jan 01 TA - medRxiv PG - 2021.08.30.21262863 4099 - http://medrxiv.org/content/early/2021/08/31/2021.08.30.21262863.short 4100 - http://medrxiv.org/content/early/2021/08/31/2021.08.30.21262863.full AB - To control the ongoing COVID-19 pandemic, CoronaVac (Sinovac), an inactivated vaccine, has been granted emergency use authorization by many countries. However, the underlying mechanisms of the inactivated COVID-19 vaccine-induced immune response remain unclear, and little is known about its features compared to SARS-CoV-2 infection. Here, we implemented single-cell RNA sequencing (scRNA-seq) to profile longitudinally collected PBMCs (peripheral blood mononuclear cells) in six individuals immunized with CoronaVac and compared these to the profiles of COVID-19 infected patients from a Single Cell Consortium. Both inactivated vaccines and SARS-CoV-2 infection drove changes in immune cell type proportions, caused B cell activation and differentiation, and induced the expression of genes associated with antibody production in the plasma. The inactivated vaccine and SARS-COV-2 infection also caused alterations in peripheral immune activity such as interferon response, inflammatory cytokine expression, innate immune cell apoptosis and migration, effector T cell exhaustion and cytotoxicity, however, the magnitude of change was greater in COVID-19 patients, especially those with severe disease, than in immunized individuals. Further analyses revealed a distinct peripheral immune cell phenotype associated with CoronaVac immunization (HLA class II upregulation and IL21R upregulation in naïve B cells) versus SARS-CoV-2 infection (HLA class II downregulation and IL21R downregulation in naïve B cells severe disease). There were also differences in the expression of important genes associated with proinflammatory cytokines and thrombosis. In conclusion, this study provides a single-cell atlas of the systemic immune response to CoronaVac immunization and reveals distinct immune responses between inactivated vaccines and SARS-CoV-2 infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementState Key Laboratory of Infectious Disease Prevention and Control (2020SKLID303), Beijing Natural Science Foundation (5214023, M21005), Public service development and reform pilot project of Beijing Medical Research Institute (BMR2019-11), National natural science foundation of China (81970900) and Beijing Social Science Foundation Project (19GLB033).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Committee of the Sanya Peoples Hospital (SYPH-2021-26).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCustom scripts for analyzing data are available upon reasonable request.